Incidence and relative risk of adverse events of special interest in patients with castration resistant prostate cancer treated with CYP-17 inhibitors: A meta-analysis of published trials
Articolo
Data di Pubblicazione:
2016
Tipologia CRIS:
1.1 Articolo in rivista
Keywords:
Abiraterone acetate; Mineralcorticoid events; Orteronel; Prostate cancer; Safety; Animals; Clinical Trials as Topic; Disease Progression; Enzyme Inhibitors; Humans; Incidence; Male; Prostatic Neoplasms, Castration-Resistant; Risk Factors; Steroid 17-alpha-Hydroxylase; Hematology; Oncology; Geriatrics and Gerontology
Elenco autori:
Roviello, Giandomenico; Sigala, Sandra; Danesi, Romano; del Re, Marzia; Bonetta, Alberto; Cappelletti, Maria Rosa; Zanotti, Laura; Bottini, Alberto; Generali, Daniele
Link alla scheda completa:
Pubblicato in: